Innovative Closed Process CAR-T Cell Therapy Platform to Streamline Approach for Manufacturing with Great Predictability

[Available On-Demand]
Search General Info
The presentation will showcase how to accelerate timeline and progress to market for CAR-T production that includes: in-stock raw materials with established batch records; regulatory and technical expertise; process and analytical development; full in-process and release testing; robust quality control and quality assurance oversight; and facilities that offer the capacity and flexibility to meet client timeline needs. The platform also offer a closed process that allow flexibility of clinical manufacturing in a shared pre-equipped suite model that will significantly increase efficiency while mitigating cost.

Speaker - Dr. Tatiana Golovina, Senior Director Cell Therapy Process Development, WuXi Advanced Therapies